Anti-oxidants for therapeutic use: Why are only a few drugs in clinical use?

Advanced Drug Delivery Reviews

Volumn 61, Issue 4, 2009, Pages 287-289

  Suzuki, Keiichiro ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Ascorbic acid; Ebselen; Edaravone; Flavonoids; Glutathione; N acetylcysteine; Superoxide dismutase; Tocopherol

Indexed keywords

ACETYLCYSTEINE; ASCORBIC ACID; DRUG DELIVERY; ENZYMES; FLAVONOIDS; OXIDANTS;

EBSELEN; EDARAVONE; GLUTATHIONES; N-ACETYLCYSTEINE; SUPER OXIDE DISMUTASE; TOCOPHEROL;

DRUG DOSAGE;

ACETYLCYSTEINE; ANTIOXIDANT; ASCORBIC ACID; EBSELEN; ENDOTOXIN; FLAVONOID; GLUTATHIONE; NORPHENAZONE; PARACETAMOL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TOCOPHEROL;

AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; BLOOD BRAIN BARRIER; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRONCHUS MUCUS; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CATARACT; CEREBROSPINAL FLUID; CHRONIC LIVER DISEASE; CORNEA INJURY; DRUG DELIVERY SYSTEM; DRUG OVERDOSE; DRUG STRUCTURE; HUMAN; INFLAMMATION; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE; SYNOVIAL FLUID;

ANIMALS; ANTIOXIDANTS; CLINICAL TRIALS AS TOPIC; HUMANS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 64149096611     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2009.03.002     Document Type: Note

References (12)

1. Houkin K., Nakayama N., Kamada K., Noujou T., Abe H., and Kashiwaba T. Neuroprotective effect of the free radical scavenger MCI-186 in patients with cerebral infarction: clinical evaluation using magnetic resonance imaging and spectroscopy. J. Stroke Cerebrovasc. Dis. 7 (1998) 315-322
2. Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc. Dis. 15 (2003) 222-229
3. Yamaguchi T., Sano K., Takakura K., Saito I., Shinohara Y., Asano T., and Yasuhara H. Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group. Stroke 29 (1998) 12-17
4. Woodman O.L., and Chan ECh. Vascular and anti-oxidant actions of flavonols and flavones. Clin. Exp. Pharmacol. Physiol. 31 (2004) 786-790
5. Lotito S.B., and Frei B. Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon?. Free Radic. Biol. Med. 41 (2006) 1727-1246
6. Somack R., Saifer M.G., and Williams L.D. Preparation of long-acting superoxide dismutase using high molecular weight polyethylene glycol (41,000-72,000 Daltons). Free Radic. Res. Commun. 12-13 (1991) 553-562
7. Shlafe M., Kane P.F., and Kirsh M.M. Superoxide dismutase plus catalase enhances the efficacy of hypothermic cardioplegia to protect the globally ischemic, reperfused heart. J. Thorac. Cardiovasc. Surg. 83 (1982) 830-839
8. Aaseth J., Haugen M., and Førre O. Rheumatoid arthritis and metal compounds-perspectives on the role of oxygen radical detoxification. Analyst 123 (1998) 3-6
9. Wellner V.P., Anderson M.E., Puri R.N., Jensen G.L., and Meister A. Radioprotection by glutathione ester: transport of glutathione ester into human lymphoid cells and fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 4732-4735
10. Cotgreave I.A. N-acetylcysteine: pharmacological considerations and experimental and clinical applications. Adv. Pharmacol. 38 (1997) 205-227
11. Jones A.L. Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: a critical review. J. Toxicol., Clin. Toxicol. 36 (1998) 277-285
12. Clarke R., and Armitage J. Antioxidant vitamins and risk of cardiovascular disease. Review of large-scale randomised trials. Cardiovasc. Drugs Ther. 16 (2002) 411-415